Indian Regorafenib Exporters: Complete Supplier Ranking with Market Share — 60 Manufacturers (2026) — TransData Nexus

Q: Who is the largest regorafenib supplier from India?

KARDI TRADING PRIVATE LIMITED is the largest regorafenib exporter from India with a 11.5% market share and export value of $116.0K.

Q: How many regorafenib suppliers are there in India?

There are 60 active regorafenib exporters in India, collectively shipping $1.0M worth of regorafenib across 154 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top regorafenib suppliers from India?

The top 5 regorafenib suppliers from India — KARDI TRADING PRIVATE LIMITED, SANSKRUTI PHARMA, R.S. SURGIPHARM PRIVATE LIMITED, 3S CORPORATION, LEOWIN HEALTHCARE LLP — together control 16.1% of total regorafenib export value from India.

Suresh Sormare

Regorafenib

India Pharmaceutical Trade Intelligence

$1.0M60 Suppliers37 CountriesHS 30049099

ExportsIndia → FRANCE73.8%India → THAILAND9.3%

ImportsUNITED STATES → India$246.8K GERMANY → India$125.9K

#1 Supplier: KARDI TRADING

Regorafenib Suppliers from India (2026) — 60 Exporters, $1.0M Market | TransData Nexus | TransData Nexus

Who Exports Regorafenib from India — 60 Suppliers Behind a $1.0M Market

India's regorafenib export market is supplied by 60 active exporters who collectively shipped $1.0M across 154 shipments. KARDI TRADING PRIVATE LIMITED leads with a 11.5% market share, followed by SANSKRUTI PHARMA and R.S. SURGIPHARM PRIVATE LIMITED. The top 5 suppliers together control 16.1% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Regorafenib Suppliers & Exporters — 60 manufacturers, $1.0M export market, top destinations and formulations — Regorafenib supplier data — 60 exporters · $1.0M market · 154 shipmentsTransData Nexus · Indian Customs Data

Top Regorafenib Exporters from India — Ranked by Export Value

KARDI TRADING PRIVATE LIMITED is the leading regorafenib exporter from India, holding a 11.5% share of the $1.0M market across 154 shipments from 60 exporters. The top 5 suppliers — KARDI TRADING PRIVATE LIMITED, SANSKRUTI PHARMA, R.S. SURGIPHARM PRIVATE LIMITED, 3S CORPORATION, LEOWIN HEALTHCARE LLP — collectively control 16.1% of total export value, indicating a competitive market. Individual shares are: KARDI TRADING PRIVATE LIMITED (11.5%), SANSKRUTI PHARMA (1.3%), R.S. SURGIPHARM PRIVATE LIMITED (1.2%), 3S CORPORATION (1.0%), LEOWIN HEALTHCARE LLP (0.9%).

Top Regorafenib Exporters from India

Ranked by export value · 60 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Regorafenib Exporters from India — Ranked by Export Value. 60 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	KARDI TRADING PRIVATE LIMITED

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Regorafenib exporters

Certification and compliance status for top Regorafenib suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
VEA IMPEX (I) PRIVATE LIMITED	Not Listed	Unknown	Unknown	Unknown	Registered with GST number 27AALFV8912H1ZP as of July 1, 2017.
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED	Not Listed	Unknown	Unknown	Unknown	Registered with GST number 27AABCB9286B1ZO as of July 1, 2017.

TransData Nexus reviewed the regulatory standing of 2 leading Regorafenib exporters from India. 0 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Regorafenib sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as India's "Bulk Drug Capital," is a central hub for the production of active pharmaceutical ingredients (APIs). The city hosts numerous API manufacturers and has a well-established infrastructure for bulk drug production. Notably, a manufacturer established in 2013 specializes in oncology, focusing on the research, manufacturing, and marketing of high-quality specialty formulations, including Regorafenib tablets. This manufacturer operates a state-of-the-art facility in Hyderabad, designed to meet global regulatory requirements, and holds GMP certifications from international regulatory authorities, including USFDA, MHRA, and PIC/S.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to major pharmaceutical companies such as Cadila Pharmaceuticals and Zydus Lifesciences, both headquartered in Ahmedabad. Cadila Pharmaceuticals, established in 1951, has grown to become one of the largest vaccine manufacturers in India. Zydus Lifesciences, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company primarily engaged in the manufacturing of generic drugs. The presence of these industry leaders underscores the region's capacity for high-quality pharmaceutical production, making it a strategic location for the formulation of drugs like Regorafenib.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Regorafenib exporters from India

December 27, 2024

M&A

Reliance Industries — Reliance Industries acquires Karkinos Healthcare for Rs 375 crore

Reliance Strategic Business Ventures Ltd, a wholly-owned subsidiary of Reliance Industries, completed the acquisition of Karkinos Healthcare Pvt Ltd, a technology-driven oncology-focused healthcare platform, for Rs 375 crore.

Impact: This acquisition is expected to enhance Reliance's presence in the healthcare sector, potentially influencing the oncology drug market dynamics.

August 25, 2025

M&A

MannKind Corporation — MannKind to acquire scPharmaceuticals, expanding into cardiorenal medicine

MannKind Corporation announced a definitive merger agreement to acquire scPharmaceuticals Inc., marking its strategic expansion into cardiorenal medicine.

Impact: This acquisition is anticipated to diversify MannKind's product portfolio, potentially affecting the competitive landscape in related pharmaceutical markets.

December 18, 2024

Common Questions — Regorafenib Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which regorafenib supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, KARDI TRADING PRIVATE LIMITED leads with 8 recorded shipments worth $116.0K. SANSKRUTI PHARMA (9 shipments) and R.S. SURGIPHARM PRIVATE LIMITED (11 shipments) are also established high-volume exporters.

Q How many regorafenib manufacturers are there in India?

India has 60 active regorafenib exporters with a combined export market of $1.0M across 154 shipments to 37 countries. The top 5 suppliers hold 16.1% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for regorafenib from India?

Average FOB unit price: $94.75 per unit, ranging from $1.84 to $365.57. Average shipment value: $6.5K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Regorafenib

Regorafenib

Who Exports Regorafenib from India — 60 Suppliers Behind a $1.0M Market

Top Regorafenib Exporters from India — Ranked by Export Value

Top Regorafenib Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Recent M&A, Collaborations & Capacity Expansions

Reliance Industries — Reliance Industries acquires Karkinos Healthcare for Rs 375 crore

MannKind Corporation — MannKind to acquire scPharmaceuticals, expanding into cardiorenal medicine

Common Questions — Regorafenib Suppliers from India

Q Which regorafenib supplier from India is the most reliable for bulk orders?

Q How many regorafenib manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for regorafenib from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Mumbai-Thane-Raigad — Export Gateway

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Cara Therapeutics and Tvardi Therapeutics — Cara Therapeutics and Tvardi Therapeutics announce merger agreement

Analysis Methodology